OptiBiotix Health PLC Increased investment in THWLC (1138T)
03 January 2017 - 7:00AM
UK Regulatory
TIDMOPTI
RNS Number : 1138T
OptiBiotix Health PLC
03 January 2017
OptiBiotix Health plc
("OptiBiotix" or the "Company")
Increased investment in The Healthy Weight Loss Company Ltd
OptiBiotix Health plc (AIM: OPTI), a life sciences business
developing compounds to tackle obesity, high cholesterol, diabetes
and skin care, announces an increase in its investment in its
majority owned subsidiary The Health Weight Loss Company Limited
("THWLC").
Under the terms of the agreement OptiBiotix has made an
investment of GBP75,000 to provide working capital to support
marketing and an increase in stock levels. This investment
increases OptiBiotix's shareholding in THWLC to 64%.
OptiBiotix announced on 26 July 2016 that it had acquired a
majority shareholding in THWLC to incubate new technological
solutions and develop wider product applications in weight
management. THWLC produces GoFigure(R) products containing
SlimBiome(R) which incorporates OptiBiotix's patented combination
of natural ingredients developed by experts to support weight loss
(see www.GoFigureDiet.com). Since investment:-
-- THWLC has gained over 1,000 customers, retail listings in
over 80 stores, and 4 distributorships in the UK and Iceland
-- Sales have outperformed expectations with GoFigure(R)
products receiving excellent customer reviews on Amazon and
customer surveys reporting average weight loss of 2 1/2 lbs per
week
-- GoFigure(R) was voted finalist in "Best New Health &
Nutrition" at the 2016 European Natural & Organic Awards
-- As announced on 13 December 2016 GoFigure(R) products have
attracted corporate interest leading to an agreement with a major
multinational to develop food and Over The Counter ("OTC") products
containing OptiBiotix's SlimBiome(R) technology for the Asian
market,
This increased investment will provide THWLC with the resources
to build on its early success to:-
1. Invest in product marketing at key seasonal periods
2. Provide the marketing support required for listing in major retail outlets
3. Increase the number of retail listings, particularly with
major retail outlets, selling GoFigure(R) products both within the
UK and internationally
Stephen O'Hara, CEO of OptiBiotix, commented: "We are really
pleased with the progress of THWLC and the rapid sales growth of
its GoFigure(R) products which have shown the unique ability of our
SlimBiome(R) technology to help customers lose weight without
feeling hungry, leading to easier and more successful dieting. Our
belief in the potential of THWLC is demonstrated by this additional
investment which provides funds to invest in marketing, to build
stock levels to meet the seasonal demand for weight management
products, and to support an increase in retail listings,
particularly with major retail outlets. I am sure investors will
recognise that given the early success of GoFigure(R) products,
which has been achieved without any marketing, there is potential
for strong sales growth of GoFigure(R) products over the next few
years and substantial value enhancement."
For further information, please contact:
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Executive Contact via
Walbrook below
Cairn Financial Advisers LLP Tel: 020 7213
0883
Liam Murray
finnCap Broker Tel: 020 7220
0500
Adrian Hargrave / Scott Mathieson
/ Kate Bannatyne (Corporate Finance)
Tony Quirke (Corporate Broking)
Walbrook PR Ltd Tel: 020 7933 8780 or
optibiotix@walbrookpr.com
Anna Dunphy Mob: 07876 741
001
Mike Wort Mob: 07900 608
002
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which
modify the human microbiome - the collective genome of the microbes
in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial
strains, compounds and formulations, which modulate the human
microbiome and can be used as food ingredients and supplements or
active compounds for the prevention and management of human
metabolic diseases, examples of which include obesity, cholesterol
and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators
that can impact on lipid and cholesterol management, energy harvest
and appetite suppression. The development pipeline is fuelled by
its proprietary OptiScreen(R) and OptiBiotic(R) platform
technologies designed to identify metabolic pathways and compounds
that impact on human physiology and bring potential health
benefits. These platforms are applicable across a wider range of
other human diseases.
About The Healthy Weight Loss Company
The Healthy Weight Loss Company (THWLC) is jointly owned by
OptiBiotix Health plc (64%), Anna Maia, and Max Tomlinson. The
Company was formed in July 2016 as a platform for OptiBiotix to
incubate new technological solutions and develop wider product
applications in weight management.
The technology incubator was created to provide an effective way
to substantiate the commercial viability of early product concepts.
THWLC sells GoFigure(R) snacks and shakes containing OptiBiotix's
proprietary Slimbiome(R) technology under a non-exclusive UK
license agreement. www.GoFigureDiet.com. The use of SlimBiome(R) in
the GoFigure(R) range establishes use of the technology in food
products and supports the wider use of Slimbiome(R) technology in
dietary supplements and over the counter (OTC) applications, both
in the UK and internationally.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBRBDDBBXBGLG
(END) Dow Jones Newswires
January 03, 2017 02:00 ET (07:00 GMT)